GlassScriptPhysician profile
Farrukh Anwar
NPI 1144268947
$1,587.77
in general payments reported to CMS, 2019-2025
19 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $161 · 2021: $15.61 · 2022: $335 · 2023: $128 · 2024: $216 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561 · Education: $43.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.95 |
| Education | $43.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $549.35 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $243.08 | 2019-2023 | |
| Amgen INC. | $158.40 | 2019-2025 | Tavneos |
| Glaxosmithkline, LLC. | $96.53 | 2019-2024 | Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $93.00 | 2020 | |
| Horizon Therapeutics Plc | $67.55 | 2019-2023 | Krystexxa |
| Novo Nordisk INC | $66.29 | 2019-2025 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $50.42 | 2023-2025 | Eohilia, Gattex |
| Janssen Biotech, INC. | $48.77 | 2022 | |
| Pfizer INC. | $44.30 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $30.55 | 2025 | Rexulti |
| Exact Sciences Corporation | $25.70 | 2023 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $25.49 | 2019 | |
| Amarin Pharma, INC. | $20.22 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.91 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $16.24 | 2024 | Arikayce |
| Allergan, INC. | $11.91 | 2019 | |
| Acadia Pharmaceuticals INC | $11.21 | 2020 | |
| Astellas Pharma US INC | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farrukh Anwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.